This inventor holds 4 USPTO granted patents and 8 published patent applications. Top assignee: Columbia University. Active years: 2020-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Scarsdale, NY (US) (2022)
- New York, NY (US) (2020 - 2023)
Company Filing History:
Years Active: 2020-2025
Title: Anil K Lalwani: Innovator in Ear Therapeutics
Introduction
Anil K Lalwani is a prominent inventor based in Scarsdale, NY (US). He has made significant contributions to the field of ear therapeutics, holding a total of 4 patents. His innovative work focuses on developing advanced medical devices aimed at improving treatments for inner ear conditions.
Latest Patents
Lalwani's latest patents include groundbreaking inventions such as an apparatus for controlled perforation and aspiration of the inner ear. This apparatus features a distal portion with a plurality of apices and valleys, which define serrated blades for effective treatment. Another notable invention is a cleavable microneedle designed for the local delivery of therapeutic agents. This microneedle includes a longitudinal body with a detachable portion that contains at least one therapeutic agent, specifically configured to administer treatments to the inner ear. Additionally, he has developed a method for preparing this microneedle using two-photon polymerization lithography.
Career Highlights
Anil K Lalwani is affiliated with Columbia University, where he continues to advance his research and innovations in the medical field. His work has garnered attention for its potential to revolutionize treatments for inner ear disorders.
Collaborations
Lalwani has collaborated with esteemed colleagues such as Jeffrey William Kysar and Aykut Aksit, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Anil K Lalwani stands out as a key figure in the development of innovative medical devices for ear therapeutics. His contributions are paving the way for new treatment options that could significantly enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
